Syneos Health™ has announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development. In this role, the Boston-based executive will oversee the company’s clinical oncology operations.
“Patrick’s extensive experience in oncology spans the development to commercial continuum, and we’re thrilled to welcome him to Syneos Health,” said Paul Colvin, President, Syneos Health Clinical Solutions. “His track record for ushering multiple oncology drugs to market, married with his operational expertise, further bolsters our ability to provide oncology customers with end-to-end solutions aimed at speeding therapies to patients.”
With 30 years of expertise across pharmaceutical, biotech and medical device sectors, Nealon has spent the last 18 years focused on developing and commercializing oncology assets. He’s gained therapeutic expertise across all phases of drug development in increasingly complex and significant oncology-focused roles, most recently as Head of Global Program Management for Oncology at Servier Pharmaceuticals, Head of Global Program Management, Hematology and Oncology at Shire, and Head of Program Management, Hematology at Baxalta.
“I’m honored to join Syneos Health where we sync clinical and commercial insights to fuel faster and smarter oncology drug development,” said Nealon. “Leveraging a therapeutically dedicated team structure, strong site and investigator relationships, and best-in-class commercial expertise, the organization is purpose-built to accelerate the delivery of innovative therapies to patients with both rare and common cancers globally.”